Board of Directors
THOMAS FEKETE, M.D., FIDSA
Temple University Medical School
Dr. Fekete graduated from Princeton (AB 1974) and Tufts Medical School (MD 1978). He trained in Internal Medicine at Rush-Presbyterian-St. Luke’s and in Infectious Diseases at the University of Chicago. He has spent his thirty-six-year academic career at Temple University School of Medicine where he served 11 years as Section Chief of Infectious Diseases and is now Chair of Medicine. His practice is in Infectious Diseases with a special interest in resistant bacteria, clinical microbiology, antibiotic stewardship and urinary tract infections.
He also has a commitment to teaching. Dr. Fekete has earned accolades for his teaching ranging from Golden Apples to the Lindback award to the Temple Great Teacher award. He has been a writer and editor for MKSAP 12-16 and a contributor for UpToDate. In 2016, he was named a Master of the American College of Physicians. He served as chair of the education committee for the Infectious Disease Society of America and had been an infectious diseases liaison to the American Board of Internal Medicine. He served on the Board of the IDSA and is now Chair of the IDSA Foundation Board. He has been on the Board of the College of Physicians of Philadelphia for twelve years and is currently Chair of the Board. He recently became the Thomas M. Durant Professor of Medicine at the Lewis Katz School of Medicine.
PAUL AUWAERTER, M.D., MBA, FIDSA
John Hopkins University
Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin.
Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center.
He earned his M.D. from the Columbia University College of Physicians and Surgeons.
His research interests include tick-borne diseases and point of care information technology.
Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America.
JOHAN S. BAKKEN, M.D., PHD, FIDSA
Retired, St. Luke’s ID Associates
Dr. Johan S. Bakken is an infectious disease specialist in Duluth, Minnesota and is affiliated with St. Luke’s Hospital-Duluth. He received his medical degree from University of Washington School of Medicine and has been in practice for more than 20 years.
SARAH LONG M.D., FIDSA
St. Christopher’s Hospital for Children
Dr. Sarah S. Long is a pediatric infectious disease specialist in Philadelphia, Pennsylvania and is affiliated with St. Christopher’s Hospital for Children. She received her medical degree from Sidney Kimmel Medical College and has been in practice for more than 20 years.
HELEN W. BOUCHER, M.D., FIDSA
Tufts Medical Center
Helen Boucher, M.D., FIDSA is chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center and director of the Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR). She is also director of the Heart Transplant and Ventricular Assist Device Infectious Diseases Program at Tufts Medical Center and a professor of medicine at Tufts University School of Medicine.
Dr. Boucher’s clinical interests include infections in immunocompromised patients and S. aureus infections. Her research interests focus on S. aureus and the development of new anti-infective agents. She is the author or coauthor of numerous abstracts, chapters and peer-reviewed articles, which have been published in such journals as The New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, and The Annals of Internal Medicine; she is Associate Editor of Antimicrobial Agents and Chemotherapy.
She has been included in Best Doctors in America since 2009. In 2011, Dr. Boucher was elected Fellow and Member of the Board of Directors of the Infectious Diseases Society of America. In 2012, she was elected to the American Board of Internal Medicine Infectious Disease Exam Writing Committee and in 2014, to the American Board of Internal Medicine Infectious Diseases Subspecialty Board.
Dr. Boucher’s drug development experience includes participating in the global development and registration of voriconazole and daptomycin, including presentation at the FDA Advisory Committee and CHMP meetings. She advises both small and large companies on antimicrobial drug development, advocates for increased research and development of new antimicrobial drugs and teaches in the annual Tufts Center for Drug Development course.
In 2015 she was appointed to the Presidential Advisory Council on Combating Antibiotic-resistant Bacteria, and elected Treasurer of the Infectious Diseases Society of America. She was awarded the IDSA Society Citation Award in October, 2015. Dr. Boucher serves on the Board of Trustees of the Physicians of Tufts Medical Center and
RUSSELL PETRAK M.D.
Metro Infectious Disease Consultants
Dr. Russell M. Petrak is a board-certified infectious disease specialist practicing in the Chicago area. He is one of the founding members and managing partner of Metro Infectious Disease Consultants, L.L.C. (MIDC), a 100 member fully integrated ID group servicing 100 hospitals and 20 offices. Founded in 1994, MIDC provides comprehensive infectious disease services including inpatient and outpatient consultation, traveler’s immunizations, and outpatient antibiotic therapy throughout Northern Illinois, Indiana, Iowa, and Michigan.
Dr. Petrak was trained at Rush Medical College and completed his internship, residency, and fellowship in infectious disease at Rush-Presbyterian-St. Luke’s Medical Center in Chicago. His first six years of practice were spent as teaching faculty at a Westside Chicago hospital before being appointed Academic Director of Medicine. As such, he served as program director for several residency programs, and directly supervised the subspecialty departments of internal medicine.
In 1997, he became a member of the Clinical Affairs Committee of IDSA and served as Chairman from 2000-2003. He remains an active member of the IDSA Outpatient Parenteral Antimicrobial Therapy Task Force, and was recently the lead author of an article entitled “The Value of an Infectious Disease Specialist.”
ELIOT W. GODOFSKY M.D., FACP, FIDSA
Bach & Godofsky
Dr. Eliot W. Godofsky is an infectious disease specialist in Bradenton, Florida and is affiliated with multiple hospitals in the area, including Blake Medical Center and Manatee Memorial Hospital. He received his medical degree from Georgetown University School of Medicine and has been in practice for more than 20 years.
BARBARA E. MURRAY, M.D.
University of Texas Health Science Center
Barbara E. Murray, MD is the J. Ralph Meadows Professor of Medicine of the ID division. She is a 1969 cum laude graduate in mathematics from Rice University in Houston, Texas (selected as a Rice Distinguished Alumna in 2015), and graduated first in her class (Ho Din Award) from the University of Texas Southwestern Medical School in Dallas in 1973.
She then spent 6 years training in Internal Medicine and Infectious Diseases at Harvard Medical School’s Massachusetts General Hospital in Boston, followed by 6 months in Thailand conducting research at the Armed Forces Research Institute of Medical Sciences. She joined the faculty at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) as an assistant professor in 1980 and became Professor in 1990, Director of the Division of Infectious Diseases in 1995, and the J. Ralph Meadows Professor in 2003.
Dr. Murray is a nationally and internationally recognized expert in antibiotic resistance, enterococci and enterococcal infections, and bacterial pathogenesis. She conducts NIH funded basic and translational research (including a prestigious 10 year MERIT award), has served on numerous NIH committees, DSMBs and study sections, including as past Chair of the NIH Recombinant DNA Advisory Committee, as well as on the FDA’s Anti-Infectives Advisory Committee; she has also served as a consultant to the pharmaceutical industry, to the European Food Safety Authority and to the EU’s Innovative Medicine’s Initiative. She has been active in professional societies including serving on the Program Planning Committee of the American Society of Microbiology’s ICAAC meeting for 9 years and as the chair for 3 years; as an editor of Antimicrobial Agents and Chemotherapy, a journal published by the American Society of Microbiology (10 year term); on the Program Committee of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); and she is a past Secretary, Treasurer and President of the Infectious Diseases Society of America and is currently she is currently chair of the IDSA Antimicrobial Resistance Committee. Dr. Murray is a frequent visiting professor at other medical schools and a frequent invited speaker at national and international meetings She received the IDSA Alexander Fleming Award for lifetime achievements in 2017.
CHRIS BUSKY, CAE
CHIEF EXECUTIVE OFFICER
Chris Busky, CAE, is the Chief Executive Officer of the Infectious Diseases Society of America (IDSA) and the IDSA Foundation.
IDSA, based in Arlington, VA, represents more than 12,000 infectious diseases (ID) physicians, scientists and advanced practice providers devoted to patient care, prevention, public health, education, and research in the area of infectious diseases.
The Society is a leader on issues of importance to ID professionals, including education and training, policy and advocacy, setting guidelines for patient care, and developing resources for clinical practice. IDSA is recognized for its sponsorship of the premier annual conference, IDWeek, and top-quality journals, and has been at the forefront of global health issues such as antimicrobial resistance and HIV/AIDS. Housed within IDSA is the HIV Medicine Association (HIVMA), which represents medical providers and researchers working on the frontlines of HIV. IDSA and HIVMA members work across the United States and in nearly 100 other countries on six different continents.
Prior to joining IDSA, Chris spent ten years as the Executive Vice President & Chief Operating Officer for the Heart Rhythm Society, an international medical society that represents healthcare professionals who specialize in the prevention and treatment of heart rhythm disorders. He has over 30 years of nonprofit management experience.
Chris received his undergraduate degree from Frostburg State University and his master’s degree from the University of Maryland.
Chis currently serves on the American Society of Association Executives’ Key Professional Association Committee.
STEPHEN CALDERWOOD, MD FIDSA
Massachusetts General Hospital
Dr. Calderwood is Emeritus Chief of Infectious Diseases at Massachusetts General Hospital and the Morton N. Swartz MD Academy Professor of Medicine (Microbiology and Immunobiology) at Harvard Medical School. During his 27 year tenure as the Chief of Infectious Diseases, he oversaw the clinical and research training of over 200 fellows training in Infectious Diseases and also ran a research lab that was continuously funded by the NIH. Dr. Calderwood also served as president of the Infectious Diseases Society of America in 2014-2015. Dr. Calderwood graduated from the Harvard Medical School in 1975.